According to A Latest intelligence report published by Market IntelliX, the global market for Cyclosporine API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Cyclosporine API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Cyclosporine API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Purity≥99% segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Capsule has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Cyclosporine API include CURIA ITALY SRL, TEVA PHARMACEUTICAL INDUSTRIES LTD, NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD, CONCORD BIOTECH LTD, APOTEX PHARMACHEM INC, CHEMWERTH INC, ABBVIE INC, CKD BIO CORP and ZHEJIANG RUIBANG LABORATORIES, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Cyclosporine API. Report Highlights:

(1) Global Cyclosporine API market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Cyclosporine API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Cyclosporine API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Cyclosporine API segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Cyclosporine API segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Cyclosporine API, capacity, production and trends.

(7) Cyclosporine API industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Purity≥99%

Purity<99%

Market segment by application, can be divided into

Capsule

Tablet

Injection

Eye Drops

Eye Gel

Eye Cream

Oral Solution

Granules

Market segment by players, this report covers

CURIA ITALY SRL

TEVA PHARMACEUTICAL INDUSTRIES LTD

NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD

CONCORD BIOTECH LTD

APOTEX PHARMACHEM INC

CHEMWERTH INC

ABBVIE INC

CKD BIO CORP

ZHEJIANG RUIBANG LABORATORIES

HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD

Guangdong Tesunde Pharmaceutical

Fujian Kerui Pharmaceutical

North China Pharmaceutical Huasheng

Sinopharm Sichuan Kang Pharmaceutical

Jiangsu Joyoung Biopharmaceuticals

1 Market Overview

1.1 Cyclosporine API Definition

1.2 Global Cyclosporine API Market Size and Forecast

1.2.1 By Revenue, Global Cyclosporine API Market Size, 2018-2029

1.2.2 By Sales Volume, Global Cyclosporine API Market Size, 2018-2029

1.2.3 Global Cyclosporine API Price Trend, 2018-2029

1.3 China Cyclosporine API Market Size and Forecast

1.3.1 By Revenue, China Cyclosporine API Market Size, 2018-2029

1.3.2 By Sales Volume, China Cyclosporine API Market Size, 2018-2029

1.3.3 China Cyclosporine API Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Cyclosporine API Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Cyclosporine API Share in Global Market, 2018-2029

1.4.3 Cyclosporine API Market Size: China VS Global, 2018-2029

1.5 Cyclosporine API Market Dynamics

1.5.1 Cyclosporine API Market Drivers

1.5.2 Cyclosporine API Market Restraints

1.5.3 Cyclosporine API Industry Trends

1.5.4 Cyclosporine API Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Cyclosporine API Revenue by Company, 2018-2023

2.2 Global Cyclosporine API Sales Volume by Company, 2018-2023

2.3 Global Cyclosporine API Price by Company, 2018-2023

2.4 Global Cyclosporine API Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Cyclosporine API Concentration Ratio

2.6 Global Cyclosporine API Mergers & Acquisitions, Expansion Plans

2.7 Global Cyclosporine API Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Cyclosporine API Revenue by Company, 2018-2023

3.2 China Cyclosporine API Sales Volume by Company, 2018-2023

3.3 China Cyclosporine API Cyclosporine API Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Cyclosporine API Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Cyclosporine API Domestic VS Export

3.6 China Market, Cyclosporine API Import & Export

3.6.1 China Market, Cyclosporine API Import & Export, 2018-2029

3.6.2 China Cyclosporine API Import & Export Trends

3.6.3 Main Sources of China Cyclosporine API Import

3.6.4 Export Destination of China Cyclosporine API

4 Cyclosporine API Production by Region

4.1 Global Cyclosporine API Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Cyclosporine API Manufacturers

4.3 Global Major Manufacturers, Cyclosporine API Capacity Expansion and Future Plans

4.4 Global Cyclosporine API Capacity by Region

4.5 Global Cyclosporine API Production by Region

4.5.1 Global Cyclosporine API Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Cyclosporine API Production by Region, 2018-2023

4.5.3 Global Cyclosporine API Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Cyclosporine API Industry Chain

5.2 Cyclosporine API Upstream Analysis

5.2.1 Cyclosporine API Core Raw Materials

5.2.2 Main Manufacturers of Cyclosporine API Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Cyclosporine API Production Mode

5.6 Cyclosporine API Procurement Model

5.7 Cyclosporine API Industry Sales Model and Sales Channels

5.7.1 Cyclosporine API Sales Model

5.7.2 Cyclosporine API Typical Distributors

6 Sights by Type

6.1 Cyclosporine API Classification

6.1.1 Purity≥99%

6.1.2 Purity<99%

6.2 By Type, Global Cyclosporine API Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Cyclosporine API Revenue, 2018-2029

6.4 By Type, Global Cyclosporine API Sales Volume, 2018-2029

6.5 By Type, Global Cyclosporine API Price, 2018-2029

7 Sights by Application

7.1 Cyclosporine API Segment by Application

7.1.1 Capsule

7.1.2 Tablet

7.1.3 Injection

7.1.4 Eye Drops

7.1.5 Eye Gel

7.1.6 Eye Cream

7.1.7 Oral Solution

7.1.8 Granules

7.2 By Application, Global Cyclosporine API Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Cyclosporine API Revenue, 2018-2029

7.4 By Application, Global Cyclosporine API Sales Volume, 2018-2029

7.5 By Application, Global Cyclosporine API Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Cyclosporine API Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Cyclosporine API Revenue, 2018-2029

8.3 By Region, Global Cyclosporine API Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Cyclosporine API Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Cyclosporine API Market Size Market Share

8.5 Europe

8.5.1 Europe Cyclosporine API Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Cyclosporine API Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Cyclosporine API Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Cyclosporine API Market Size Market Share

8.7 South America

8.7.1 South America Cyclosporine API Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Cyclosporine API Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Cyclosporine API Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Cyclosporine API Revenue, 2018-2029

9.3 By Country, Global Cyclosporine API Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Cyclosporine API Market Size, 2018-2029

9.4.2 By Company, U.S. Cyclosporine API Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Cyclosporine API Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Cyclosporine API Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Cyclosporine API Market Size, 2018-2029

9.5.2 By Company, Europe Cyclosporine API Sales Volume Market Share, 2022

9.5.3 By Type, Europe Cyclosporine API Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Cyclosporine API Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Cyclosporine API Market Size, 2018-2029

9.6.2 By Company, China Cyclosporine API Sales Volume Market Share, 2022

9.6.3 By Type, China Cyclosporine API Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Cyclosporine API Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Cyclosporine API Market Size, 2018-2029

9.7.2 By Company, Japan Cyclosporine API Sales Volume Market Share, 2022

9.7.3 By Type, Japan Cyclosporine API Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Cyclosporine API Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Cyclosporine API Market Size, 2018-2029

9.8.2 By Company, South Korea Cyclosporine API Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Cyclosporine API Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Cyclosporine API Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Cyclosporine API Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Cyclosporine API Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Cyclosporine API Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Cyclosporine API Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Cyclosporine API Market Size, 2018-2029

9.10.2 By Company, India Cyclosporine API Sales Volume Market Share, 2022

9.10.3 By Type, India Cyclosporine API Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Cyclosporine API Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Cyclosporine API Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Cyclosporine API Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Cyclosporine API Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Cyclosporine API Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 CURIA ITALY SRL

10.1.1 CURIA ITALY SRL Company Information, Head Office, Market Area and Industry Position

10.1.2 CURIA ITALY SRL Cyclosporine API Models, Specifications and Application

10.1.3 CURIA ITALY SRL Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 CURIA ITALY SRL Company Profile and Main Business

10.1.5 CURIA ITALY SRL Recent Developments

10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

10.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information, Head Office, Market Area and Industry Position

10.2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Models, Specifications and Application

10.2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Profile and Main Business

10.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments

10.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD

10.3.1 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Information, Head Office, Market Area and Industry Position

10.3.2 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Models, Specifications and Application

10.3.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Profile and Main Business

10.3.5 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Recent Developments

10.4 CONCORD BIOTECH LTD

10.4.1 CONCORD BIOTECH LTD Company Information, Head Office, Market Area and Industry Position

10.4.2 CONCORD BIOTECH LTD Cyclosporine API Models, Specifications and Application

10.4.3 CONCORD BIOTECH LTD Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 CONCORD BIOTECH LTD Company Profile and Main Business

10.4.5 CONCORD BIOTECH LTD Recent Developments

10.5 APOTEX PHARMACHEM INC

10.5.1 APOTEX PHARMACHEM INC Company Information, Head Office, Market Area and Industry Position

10.5.2 APOTEX PHARMACHEM INC Cyclosporine API Models, Specifications and Application

10.5.3 APOTEX PHARMACHEM INC Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 APOTEX PHARMACHEM INC Company Profile and Main Business

10.5.5 APOTEX PHARMACHEM INC Recent Developments

10.6 CHEMWERTH INC

10.6.1 CHEMWERTH INC Company Information, Head Office, Market Area and Industry Position

10.6.2 CHEMWERTH INC Cyclosporine API Models, Specifications and Application

10.6.3 CHEMWERTH INC Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 CHEMWERTH INC Company Profile and Main Business

10.6.5 CHEMWERTH INC Recent Developments

10.7 ABBVIE INC

10.7.1 ABBVIE INC Company Information, Head Office, Market Area and Industry Position

10.7.2 ABBVIE INC Cyclosporine API Models, Specifications and Application

10.7.3 ABBVIE INC Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 ABBVIE INC Company Profile and Main Business

10.7.5 ABBVIE INC Recent Developments

10.8 CKD BIO CORP

10.8.1 CKD BIO CORP Company Information, Head Office, Market Area and Industry Position

10.8.2 CKD BIO CORP Cyclosporine API Models, Specifications and Application

10.8.3 CKD BIO CORP Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 CKD BIO CORP Company Profile and Main Business

10.8.5 CKD BIO CORP Recent Developments

10.9 ZHEJIANG RUIBANG LABORATORIES

10.9.1 ZHEJIANG RUIBANG LABORATORIES Company Information, Head Office, Market Area and Industry Position

10.9.2 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Models, Specifications and Application

10.9.3 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 ZHEJIANG RUIBANG LABORATORIES Company Profile and Main Business

10.9.5 ZHEJIANG RUIBANG LABORATORIES Recent Developments

10.10 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD

10.10.1 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

10.10.2 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Models, Specifications and Application

10.10.3 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Profile and Main Business

10.10.5 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Recent Developments

10.11 Guangdong Tesunde Pharmaceutical

10.11.1 Guangdong Tesunde Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.11.2 Guangdong Tesunde Pharmaceutical Cyclosporine API Models, Specifications and Application

10.11.3 Guangdong Tesunde Pharmaceutical Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Guangdong Tesunde Pharmaceutical Company Profile and Main Business

10.11.5 Guangdong Tesunde Pharmaceutical Recent Developments

10.12 Fujian Kerui Pharmaceutical

10.12.1 Fujian Kerui Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.12.2 Fujian Kerui Pharmaceutical Cyclosporine API Models, Specifications and Application

10.12.3 Fujian Kerui Pharmaceutical Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Fujian Kerui Pharmaceutical Company Profile and Main Business

10.12.5 Fujian Kerui Pharmaceutical Recent Developments

10.13 North China Pharmaceutical Huasheng

10.13.1 North China Pharmaceutical Huasheng Company Information, Head Office, Market Area and Industry Position

10.13.2 North China Pharmaceutical Huasheng Cyclosporine API Models, Specifications and Application

10.13.3 North China Pharmaceutical Huasheng Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 North China Pharmaceutical Huasheng Company Profile and Main Business

10.13.5 North China Pharmaceutical Huasheng Recent Developments

10.14 Sinopharm Sichuan Kang Pharmaceutical

10.14.1 Sinopharm Sichuan Kang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.14.2 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Models, Specifications and Application

10.14.3 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Sinopharm Sichuan Kang Pharmaceutical Company Profile and Main Business

10.14.5 Sinopharm Sichuan Kang Pharmaceutical Recent Developments

10.15 Jiangsu Joyoung Biopharmaceuticals

10.15.1 Jiangsu Joyoung Biopharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.15.2 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Models, Specifications and Application

10.15.3 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Jiangsu Joyoung Biopharmaceuticals Company Profile and Main Business

10.15.5 Jiangsu Joyoung Biopharmaceuticals Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Cyclosporine API Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Cyclosporine API Market Restraints

Table 3. Cyclosporine API Market Trends

Table 4. Cyclosporine API Industry Policy

Table 5. Global Cyclosporine API Revenue by Company, 2018-2023, US$ million

Table 6. Global Cyclosporine API Revenue Market Share by Company, 2018-2023

Table 7. Global Cyclosporine API Sales Volume by Company, 2018-2023, (Tons)

Table 8. Global Cyclosporine API Sales Volume Market Share by Company, 2018-2023

Table 9. Global Cyclosporine API Price by Company, 2018-2023, (US$/Ton)

Table 10. Global Cyclosporine API Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cyclosporine API Mergers & Acquisitions, Expansion Plans

Table 12. Global Cyclosporine API Manufacturers Product Type

Table 13. China Cyclosporine API Revenue by Company, 2018-2023, US$ million

Table 14. China Cyclosporine API Revenue Market Share by Company, 2018-2023

Table 15. China Cyclosporine API Sales Volume by Company, 2018-2023, (Tons)

Table 16. China Cyclosporine API Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Cyclosporine API Production, Sales, Import and Export, 2018-2029, (Tons)

Table 18. China Cyclosporine API Import & Export Trends

Table 19. Main Sources of China Cyclosporine API Import

Table 20. Export Destination of China Cyclosporine API

Table 21. Global Headquarters and Manufacturing Base of Cyclosporine API Manufacturers

Table 22. Global Major Manufacturers, Cyclosporine API Capacity Expansion and Future Plans

Table 23. Global Cyclosporine API Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)

Table 24. Global Cyclosporine API Production by Region, 2018-2023, (Tons)

Table 25. Global Cyclosporine API Production Forecast by Region, 2023-2029, (Tons)

Table 26. Global Key Players of Cyclosporine API Upstream (Raw Materials)

Table 27. Global Cyclosporine API Typical Customers

Table 28. Cyclosporine API Typical Distributors

Table 29. By Type, Global Cyclosporine API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Cyclosporine API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Cyclosporine API Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Cyclosporine API Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Cyclosporine API Sales Volume, 2018-2029, (Tons)

Table 34. By Country, Global Cyclosporine API Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Cyclosporine API Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Cyclosporine API Revenue Market Share, 2018-2029

Table 37. By Country, Global Cyclosporine API Sales Volume, 2018-2029, (Tons)

Table 38. By Country, Global Cyclosporine API Sales Volume Market Share, 2018-2029

Table 39. CURIA ITALY SRL Company Information, Head Office, Market Area and Industry Position

Table 40. CURIA ITALY SRL Cyclosporine API Models, Specifications and Application

Table 41. CURIA ITALY SRL Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 42. CURIA ITALY SRL Company Profile and Main Business

Table 43. CURIA ITALY SRL Recent Developments

Table 44. TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information, Head Office, Market Area and Industry Position

Table 45. TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Models, Specifications and Application

Table 46. TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 47. TEVA PHARMACEUTICAL INDUSTRIES LTD Company Profile and Main Business

Table 48. TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments

Table 49. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Information, Head Office, Market Area and Industry Position

Table 50. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Models, Specifications and Application

Table 51. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 52. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Profile and Main Business

Table 53. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Recent Developments

Table 54. CONCORD BIOTECH LTD Company Information, Head Office, Market Area and Industry Position

Table 55. CONCORD BIOTECH LTD Cyclosporine API Models, Specifications and Application

Table 56. CONCORD BIOTECH LTD Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 57. CONCORD BIOTECH LTD Company Profile and Main Business

Table 58. CONCORD BIOTECH LTD Recent Developments

Table 59. APOTEX PHARMACHEM INC Company Information, Head Office, Market Area and Industry Position

Table 60. APOTEX PHARMACHEM INC Cyclosporine API Models, Specifications and Application

Table 61. APOTEX PHARMACHEM INC Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 62. APOTEX PHARMACHEM INC Company Profile and Main Business

Table 63. APOTEX PHARMACHEM INC Recent Developments

Table 64. CHEMWERTH INC Company Information, Head Office, Market Area and Industry Position

Table 65. CHEMWERTH INC Cyclosporine API Models, Specifications and Application

Table 66. CHEMWERTH INC Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 67. CHEMWERTH INC Company Profile and Main Business

Table 68. CHEMWERTH INC Recent Developments

Table 69. ABBVIE INC Company Information, Head Office, Market Area and Industry Position

Table 70. ABBVIE INC Cyclosporine API Models, Specifications and Application

Table 71. ABBVIE INC Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 72. ABBVIE INC Company Profile and Main Business

Table 73. ABBVIE INC Recent Developments

Table 74. CKD BIO CORP Company Information, Head Office, Market Area and Industry Position

Table 75. CKD BIO CORP Cyclosporine API Models, Specifications and Application

Table 76. CKD BIO CORP Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 77. CKD BIO CORP Company Profile and Main Business

Table 78. CKD BIO CORP Recent Developments

Table 79. ZHEJIANG RUIBANG LABORATORIES Company Information, Head Office, Market Area and Industry Position

Table 80. ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Models, Specifications and Application

Table 81. ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 82. ZHEJIANG RUIBANG LABORATORIES Company Profile and Main Business

Table 83. ZHEJIANG RUIBANG LABORATORIES Recent Developments

Table 84. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area and Industry Position

Table 85. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Models, Specifications and Application

Table 86. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 87. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Profile and Main Business

Table 88. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Recent Developments

Table 89. Guangdong Tesunde Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 90. Guangdong Tesunde Pharmaceutical Cyclosporine API Models, Specifications and Application

Table 91. Guangdong Tesunde Pharmaceutical Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 92. Guangdong Tesunde Pharmaceutical Company Profile and Main Business

Table 93. Guangdong Tesunde Pharmaceutical Recent Developments

Table 94. Fujian Kerui Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 95. Fujian Kerui Pharmaceutical Cyclosporine API Models, Specifications and Application

Table 96. Fujian Kerui Pharmaceutical Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 97. Fujian Kerui Pharmaceutical Company Profile and Main Business

Table 98. Fujian Kerui Pharmaceutical Recent Developments

Table 99. North China Pharmaceutical Huasheng Company Information, Head Office, Market Area and Industry Position

Table 100. North China Pharmaceutical Huasheng Cyclosporine API Models, Specifications and Application

Table 101. North China Pharmaceutical Huasheng Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 102. North China Pharmaceutical Huasheng Company Profile and Main Business

Table 103. North China Pharmaceutical Huasheng Recent Developments

Table 104. Sinopharm Sichuan Kang Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 105. Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Models, Specifications and Application

Table 106. Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 107. Sinopharm Sichuan Kang Pharmaceutical Company Profile and Main Business

Table 108. Sinopharm Sichuan Kang Pharmaceutical Recent Developments

Table 109. Jiangsu Joyoung Biopharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 110. Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Models, Specifications and Application

Table 111. Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023

Table 112. Jiangsu Joyoung Biopharmaceuticals Company Profile and Main Business

Table 113. Jiangsu Joyoung Biopharmaceuticals Recent Developments

List of Figure

Figure 1. Cyclosporine API Picture

Figure 2. By Revenue, Global Cyclosporine API Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Cyclosporine API Market Size and Forecast, 2018-2029, (Tons)

Figure 4. Global Cyclosporine API Price Trend, 2018-2029, (US$/Ton)

Figure 5. By Revenue, China Cyclosporine API Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Cyclosporine API Market Size and Forecast, 2018-2029, (Tons)

Figure 7. China Cyclosporine API Price Trend, 2018-2029 (US$/Ton)

Figure 8. By Revenue, China Cyclosporine API Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Cyclosporine API Share of Global Market, 2018-2029

Figure 10. Global Cyclosporine API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Cyclosporine API Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Cyclosporine API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Cyclosporine API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Cyclosporine API Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Cyclosporine API Domestic VS Export, 2022

Figure 16. Global Cyclosporine API Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Cyclosporine API Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Cyclosporine API Production Market Share & Forecast by Region, 2018-2029

Figure 19. Cyclosporine API Industry Chain

Figure 20. Cyclosporine API Procurement Model

Figure 21. Cyclosporine API Sales Model

Figure 22. Cyclosporine API Sales Channels, Direct Sales and Distribution

Figure 23. Purity≥99%

Figure 24. Purity<99%

Figure 25. By Type, Global Cyclosporine API Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Cyclosporine API Revenue Market Share, 2018-2029

Figure 27. By Type, Global Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 28. By Type, Global Cyclosporine API Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Cyclosporine API Price, 2018-2029, (US$/Ton)

Figure 30. Capsule

Figure 31. Tablet

Figure 32. Injection

Figure 33. Eye Drops

Figure 34. Eye Gel

Figure 35. Eye Cream

Figure 36. Oral Solution

Figure 37. Granules

Figure 38. By Application, Global Cyclosporine API Revenue, 2018-2029, US$ Million

Figure 39. By Application, Global Cyclosporine API Revenue Market Share, 2018-2029

Figure 40. By Application, Global Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 41. By Application, Global Cyclosporine API Sales Volume Market Share, 2018-2029

Figure 42. By Application, Global Cyclosporine API Price, 2018-2029, (US$/Ton)

Figure 43. By Region, Global Cyclosporine API Revenue Market Share, 2018-2029

Figure 44. By Region, Global Cyclosporine API Sales Volume Market Share, 2018-2029

Figure 45. North America Cyclosporine API Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, North America Cyclosporine API Revenue Market Share, 2022

Figure 47. Europe Cyclosporine API Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country, Europe Cyclosporine API Revenue Market Share, 2022

Figure 49. Asia Pacific Cyclosporine API Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. By Country/Region, Asia Pacific Cyclosporine API Revenue Market Share, 2022

Figure 51. South America Cyclosporine API Revenue & Forecasts, 2018-2029, US$ Million

Figure 52. By Country, South America Cyclosporine API Revenue Market Share, 2022

Figure 53. Middle East & Africa Cyclosporine API Revenue & Forecasts, 2018-2029, US$ Million

Figure 54. U.S. Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 55. By Company, U.S. Cyclosporine API Market Share, 2022

Figure 56. By Type, U.S. Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, U.S. Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 58. Europe Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 59. By Company, Europe Cyclosporine API Market Share, 2022

Figure 60. By Type, Europe Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, Europe Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 62. China Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 63. By Company, China Cyclosporine API Market Share, 2022

Figure 64. By Type, China Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, China Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 66. Japan Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 67. By Company, Japan Cyclosporine API Market Share, 2022

Figure 68. By Type, Japan Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, Japan Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 70. South Korea Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 71. By Company, South Korea Cyclosporine API Market Share, 2022

Figure 72. By Type, South Korea Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, South Korea Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 74. Southeast Asia Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 75. By Company, Southeast Asia Cyclosporine API Market Share, 2022

Figure 76. By Type, Southeast Asia Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, Southeast Asia Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 78. India Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 79. By Company, India Cyclosporine API Market Share, 2022

Figure 80. By Type, India Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, India Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 82. Middle East & Asia Cyclosporine API Sales Volume, 2018-2029, (Tons)

Figure 83. By Company, Middle East & Asia Cyclosporine API Market Share, 2022

Figure 84. By Type, Middle East & Asia Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 85. By Application, Middle East & Asia Cyclosporine API Sales Volume Market Share, 2022 VS 2029

Figure 86. Research Methodology

Figure 87. Breakdown of Primary Interviews

Figure 88. Bottom-up Approaches

Figure 89. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)